References
- Lowy F D. Staphylococcus aureus infections. N Engl J Med. 1998; 20(8)520–32, 339
- Lyon B R, Skurray R. Antibiotic resistance of Staphylococcus aureus: genetic basis. Microbiol Rev Mar, 1987; 88–134
- Benner E J, Kayser F H. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet. 1968; 2: 741
- Inglis B, Matthews P R, Stewart P R. The expression in Staphylococcus aureus of cloned DNA encoding methicillin resistance. J Gen Microbiol. 1988; 134: 1465
- Kuehnert M J, Hill H A, Kupronis H A, Tokers J I, Solomon S L, Jernigan D B. Methicillin-resistant Staphylococcus aureus Hospitalizations, United States. Emerg Infect Dis. 2005; 11: 868–72
- Romero-Vivas J, Rubio M, Fernandez C, Picazzo J J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1995; 21: 1417–23
- Chambers S. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001; 29(4)187–90
- Devive J, Cooke R PD, Wright E P. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission andhandwashing compliance?. J Hosp Infect. 2001; 48: 72–5
- Lally R T, Ederer M N, Woolfrey B F. Evaluation of Mannitol Salt Agar with Oxacillin as a Screening Medium for Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol. 1985; 22(4)501–4
- Todd B. Beyond MRSA: VISA andVRSA: what will ward off these pathogens in health care facilities?. Am J Nurs 2006; 106(4)28–30